Government supply services: NHS, NUPCO, KEMSA, MSD, NMS, donor-funded — Indian WHO-GMP origin.
Government tender desks across 45 markets source pharmaceutical product from India where the price-quality combination matches the procurement specification. M Care is the manufacturer-side partner running the tender response, the regulatory dossier, the in-tender clarification cycle, and the multi-quarter standing-order dispatch — across NHS framework agreements, GCC central tenders, African medical stores authorities, and donor-funded pooled procurement.
Tender. Standing order. Multi-country campaign. Donor-funded pooled procurement.
Government pharmaceutical procurement runs on tender frameworks — periodic public RFPs published by national medical stores authorities, ministries of health, NHS framework holders, and donor-funded pooled procurement mechanisms. M Care's government-supply work covers the full tender lifecycle: scope match, dossier preparation, tender response submission, in-tender clarification cycle, award-stage activation, and the multi-quarter standing-order dispatch that delivers the awarded supply.
Who the route serves
NHS Supply Chain framework agreement holders (UK), NUPCO and the Saudi Ministry of Health (Saudi Arabia), MoHAP federal procurement and DHA / DOH Abu Dhabi (UAE), NHRA / KDFC / MoH Oman / MoPH Qatar (GCC), KEMSA / MEDS / MSD / NMS / EPSS / Central Medical Stores Ghana (Africa), KIMADIA / JPD (Middle East), FDA Philippines DOH Procurement (ASEAN), Global Fund PPM and GAVI / UNICEF Supply Division (donor-funded). M Care has supplied across 45+ destination countries' government tender desks.
Where we sit in it
Manufacturer-side. We are not the destination importer of record (typically a national medical stores authority or its appointed importer holds the import licence). We are the Indian WHO-GMP facility's commercial and regulatory arm, sourcing the molecule, preparing the tender dossier in the destination authority's required format, running the in-tender clarification cycle, and coordinating the multi-quarter dispatch against the awarded supply schedule.
What the tender desk gets
A tender response in the destination authority's exact format (CTD harmonised to GHC central registration, NAFDAC product registration, SAHPRA Section 21, NHS framework specification, etc.), with the manufacturer-side documentation pre-built — eliminating the back-and-forth that adds 4-8 weeks to a typical Indian-source tender response.
Why a government tender desk phones us.
RFP scope match
A tender RFP requires a specific molecule, strength, dosage form and quantity at a specific landed price. We confirm the manufacturer match against the spec, the dossier match against the destination authority's format, and a landed price within the tender response window — typically 10-21 days against most destination authorities' RFP cycle.
Multi-country lane consistency
Donor-funded pooled procurement (Global Fund PPM, GAVI / UNICEF) runs multi-country awards where the same molecule from the same manufacturer ships to 5-25 destination countries on a coordinated schedule. M Care arranges standing-order campaigns from the manufacturing partner with destination-by-destination dispatch coordination.
NHS framework activation
An NHS framework agreement award triggers a multi-quarter standing-order against the framework's price schedule. We dispatch from the Indian manufacturing partner against the framework's call-off schedule, with cold-chain handling where the molecule requires it and pharmacovigilance routing maintained for the framework's duration.
Emergency or shortage tender
An emergency tender during a national medicine shortage runs on a 5-15-day response cycle. Where the shortage molecule sits in M Care's stocked-on-hand range across our manufacturing partner network, we can quote against the emergency spec inside one working day and ship the first batch inside 5-10 calendar days.
Every document a government tender RFP asks for.
Prepared at the Indian end against the destination authority's exact format. CTD harmonised to the destination registration framework; manufacturer-side audit trail filed alongside the tender response.
CTD dossier (destination format)
Common Technical Document harmonised to the destination authority's required format — CTD Module 1 for MHRA / EU, GHC central registration format for GCC central tenders, NAFDAC product registration for Nigeria, SAHPRA Section 21 for South Africa, KEMSA framework specification for Kenya, etc.
Manufacturer-site audit pack
Manufacturing licence, WHO-GMP certificate, manufacturing batch records, recent on-site inspection reports (PIC/S, WHO PQ, country-specific where applicable). Filed alongside the tender response for the destination authority's QA review.
Stability and bioequivalence data
Destination-zone stability data (typically Zone IVb for Africa / South Asia, Zone II for EU, mixed for GCC). Bioequivalence study report referenced to the destination authority's reference standard where required.
Destination-language label set
Destination-language SmPC, patient information leaflet, and carton labelling — Arabic for GCC tenders, French for francophone West Africa, Portuguese for Mozambique and PALOP countries, Spanish for LatAm tenders, where the tender requires destination-language packaging.
Commercial terms and price schedule
Tender-response commercial volume comprising landed price per unit, payment terms, dispatch schedule against the tender's call-off, performance bond / bid bond where required, and the multi-quarter price-stability commitment.
Standing-order activation pack
Once awarded, the standing-order activation pack — quarterly batch dispatch schedule, batch-specific CoA per dispatch, packaging confirmation, courier coordination, and the destination importer's call-off interface. Maintained for the tender's duration.
RFP scope match · dossier prep · tender submission · clarification · award activation.
- RFP scope match. Within 24-48 hours of the tender RFP's publication or your forwarding it to us: molecule match against our manufacturing-partner panel, dossier-format match against the destination authority's requirements, landed-price quote against the tender spec, and the dispatch-schedule commitment against the tender's call-off.
- Dossier preparation. CTD harmonised to the destination authority's format, manufacturer-site audit pack, destination-zone stability data, BE reference where required, destination-language label set. Prepared at the Indian end and cross-checked against the tender RFP's exact specification.
- Tender response submission. Submission against the destination authority's deadline, in the format specified — typically a sealed-bid technical and commercial volume separately, with the technical volume containing the dossier and audit pack, and the commercial volume containing the price schedule and standing-order commitment.
- In-tender clarification cycle. Most tenders trigger a clarification cycle 2-4 weeks after submission, where the destination authority queries specific dossier items, manufacturing-site audit clarifications, or commercial-term refinements. We respond within the authority's clarification deadline (typically 5-10 working days).
- Award activation and standing-order dispatch. Award notification triggers the standing-order activation: first-batch dispatch against the tender's call-off schedule, quarterly batch dispatches for the tender's duration, batch-by-batch QA sign-off and pharmacovigilance routing maintained for the framework's lifecycle. Re-tendering coordination 6-12 months ahead of the tender's expiry.
Government supply services — the specifics.
Are you the importer of record for a government tender?
No. The destination authority's appointed importer (typically the national medical stores authority or its tendered importer) holds the import licence. We are the Indian manufacturer-side partner — we supply the molecule, the dossier, the tender response, and the multi-quarter dispatch. The importer of record handles the destination-side regulatory clearance.
Which government tenders have you supplied into?
NHS Supply Chain framework agreements (UK), NUPCO Saudi Arabia, MoHAP UAE federal procurement, KEMSA Kenya, MEDS Kenya, MSD Tanzania, NMS Uganda, EPSS Ethiopia, KIMADIA Iraq, JPD Jordan, FDA Philippines DOH Procurement (ASEAN), Global Fund Pooled Procurement Mechanism, GAVI / UNICEF Supply Division. Detailed list available against signed NDA at quotation stage.
What's the typical tender response timeline?
From RFP publication to tender submission: 10-21 days against most destination authorities' RFP cycle. Emergency / shortage tenders run on 5-15-day cycles. Multi-country donor-funded pooled procurement runs longer (4-8 weeks) due to the multi-country dossier harmonisation.
How do you handle the in-tender clarification cycle?
Most tenders trigger a clarification cycle 2-4 weeks after submission. The destination authority queries specific dossier items, manufacturing-site audit clarifications, or commercial-term refinements. We respond within the authority's clarification deadline (typically 5-10 working days). Manufacturer-side queries route to the Indian partner's regulatory affairs team within 24-48 hours.
Can you supply against a multi-quarter standing-order schedule?
Yes. Most government tender awards are multi-quarter standing orders running 12-36 months. We arrange standing-order campaigns at the manufacturing partner's site, with quarterly batch dispatches scheduled against the tender's call-off, and the standing-order activation pack maintained for the tender's duration.
Do you support donor-funded pooled procurement (Global Fund, GAVI, UNICEF)?
Yes — manufacturer-side. The donor (Global Fund PPM, GAVI / UNICEF Supply Division) holds the procurement contract with the manufacturer; M Care's role is to coordinate the multi-country dispatch against the donor's award schedule. WHO PQ status maintained for the molecules where the donor procurement requires PQ-listed sources.
What's your strongest tender geography?
Most active tender supply: NHS framework (UK), NUPCO and Saudi MoH Central Drug Store (Saudi Arabia), KEMSA / MEDS / MSD / NMS / EPSS (East Africa medical stores), Global Fund PPM (multi-country), KIMADIA Iraq. Strong in oncology cytotoxics, anti-infectives, anaesthesia / ICU, vaccines and biologicals tender responses.
How do you manage risk during a tender's standing-order phase?
Performance bond or bid bond posted at award where required. Multi-quarter price-stability commitment maintained. Manufacturer-side capacity reserved against the tender's quarterly call-off. Pharmacovigilance routing maintained for the framework's lifecycle. Re-tendering coordination 6-12 months ahead of the tender's expiry to maintain continuity.
An RFP, a destination tender desk, an Indian manufacturer-side response. That's the conversation.
Tender authority, RFP scope, target submission date, multi-quarter call-off. We'll have a manufacturer-side answer inside one working day.